Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;14(7-8):494-500.
doi: 10.3109/21678421.2013.817585. Epub 2013 Jul 30.

Bulbar and speech motor assessment in ALS: challenges and future directions

Affiliations
Free PMC article

Bulbar and speech motor assessment in ALS: challenges and future directions

Jordan R Green et al. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec.
Free PMC article

Abstract

Bulbar motor deterioration due to amyotrophic lateral sclerosis (ALS) leads to the eventual impairment of speech and swallowing functions. Despite these devastating consequences, no standardized diagnostic procedure for assessing bulbar dysfunction in ALS exists and adequate objective markers of bulbar deterioration have not been identified. In this paper, we consider objective measures of speech motor function, which show promise for forming the basis of a comprehensive, quantitative bulbar motor assessment in ALS. These measures are based on the assessment of four speech subsystems: respiratory, phonatory, articulatory, and resonatory. The goal of this research is to design a non-invasive, comprehensive bulbar motor assessment instrument intended for early detection, monitoring of disease progression, and clinical trial application. Preliminary data from an ongoing study of bulbar motor decline are presented, which demonstrate the potential clinical efficacy of the speech subsystem approach.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The four speech subsystems.
Figure 2.
Figure 2.
The mean values and standard error for each group and variable. Statistically significant comparisons are marked with horizontal brackets.
Figure 3.
Figure 3.
Effect sizes for each speech variable representing the differences between the healthy controls and the ALS participants with normal speech intelligibly. Statistically significant comparisons are marked with asterisks.
Figure 4.
Figure 4.
Effect sizes for each speech variable representing the differences between participants with ALS who had normal speech and who had impaired speech. Statistically significant comparisons are marked with asterisks.

References

    1. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707–19. - PubMed
    1. Armon C, Moses D. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci. 1998;160:37–41. - PubMed
    1. del Aguila MA, Longstreth WT, Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9. - PubMed
    1. Ball L, Beukelman DR, Pattee G. Timing of speech deterioration in people with amyotrophic lateral sclerosis. J Med Speech-Lang Pa. 2002;10:231–5.
    1. Yunusova Y, Green JR, Wang J, Pattee G, Zinman L. A protocol for comprehensive assessment of bulbar dysfunction in amyotrophic lateral sclerosis (ALS) J Vis Exp. 2011;21((48)) doi:pii: 2422. 10.3791/2422. - PMC - PubMed

Publication types